Gene Vector Technologies LTD
Gene Vector Technologies (GVT) core technology is a new platform for gene therapy. Many current approaches rely on the use of active viruses to deliver therapeutic genetic material. However, as with live-virus vaccines, this therapeutic use of viruses risks serious side-effects in a small number of the patients treated. Instead of using 'live' viruses to deliver genetic materials, GVT's technology represents a change of paradigm. Instead of using a live virus or potentially toxic chemical treatment, GVT uses only a small set of viral proteins to assemble its delivery vector. The result is a lab-manufactured pseudo-virus made from controlled compounds that can deliver genes into the body while avoiding hazards of an active virus. CWT is currently investigating collaborations on GVT technology.